Alfred A. Knopf

Bad Blood: Secrets and Lies in a Silicon Valley Startup by John Carreyrou
Published by Alfred A. Knopf on May 21, 2018
Pages: 341
Format: ebook
Genres: High-Stakes Science, Medicine, Nonfiction
See it @ Goodreads

Synopsis

The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.

For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.

Who would have thought that a blonde haired, blue eyed nineteen-year-old drop out from Stanford University could have fooled so many, for so long? That is precisely what Elizabeth Holmes did when she incorporated her company Real-Time Cures, later renamed Theranos. By the end of 2004, Elizabeth had raised more than 6 million dollars. Before it all over Theranos had over 800 employees and a paper valuation of $9 billion. 

What happened at Theranos is a reflection of what is most common in our society today. A willingness to believe in something that can not possibly be true, a desire to follow an individual without rational thought or cause. How could someone deceive so many people for so long? What motivated Holmes to persist in this delusion? Holmes endangered thousands of lives by processing blood test without suffice blood samples. She has misled investors, terrorized employees and generally lied at every opportunity. 

This week Theranos was dissolved, it no longer exists, Elizabeth Holmes is facing criminal charges that could cost her 20 years in prison.